Showing posts with label Pharmacovigilance (PV) Market. Show all posts
Showing posts with label Pharmacovigilance (PV) Market. Show all posts

Thursday, June 3, 2021

Pharmacovigilance (PV) Market Growth Opportunities and Forecast to 2025

The Global Pharmacovigilance (PV) Market Report offers details on current and future growth trends pertaining to the business besides information on numerous regions across the geographical landscape of the Pharmacovigilance (PV) Market. The study includes global, regional, and country-level market size, shares, growth rate analysis (include the causes of highest and lowest peak industry analysis), product launches, latest trends, the impact of covid19 on worldwide.

 

Pharmacovigilance (PV) Market Research Methodology overview consists of primary and secondary research, company share analysis, model (including Demographic data, Macroeconomic indicators, and Industry indicators i.e. Expenditure, infrastructure, sector growth, and facilities, etc), Research Limitations, and Revenue Based Modelling. Comprehensive analysis of Pharmacovigilance (PV) Market based on current & future analysis depending on historic data also featured in this Report.

 

Get Free PDF Sample (Including Full TOC, List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/pharmacovigilance-pv-market/request-sample                                     

 

The global Pharmacovigilance (PV) Market size is estimated to reach USD 10.27 billion by 2025, registering at a 13.1% CAGR over the forecast period as the scope and its applications are rising enormously across the globe. Pharmacovigilance (PV) is also termed as drug safety, is a science and activities relating to the prevention, detection, understanding, and assessment of adverse effects or other drug-related issues.

 

The factors that are playing a major role in the growth of pharmacovigilance market are the rising occurrence of adverse drug reactions (ADR), enhancement in development of ADR database and information system, and the rising demand from the end-users. Pharmacovigilance (PV) industry is segmented based on the clinical trial phase, service provider, type of methods, end-user, and region.

 

Globally, North America accounted for the substantial share of pharmacovigilance industry and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be the presence of key manufacturers in the region and the high investment in the development of new drugs. The United States and Canada are the major consumers of pharmacovigilance in the years to come.

 

Table of Contents:-

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Pharmacovigilance (PV): Market Variables, Trends & Scope              

Chapter 4 Pharmacovigilance (PV): Product Estimates & Trend Analysis

Chapter 5 Pharmacovigilance (PV): Application Estimates & Trend Analysis

Chapter 6 Pharmacovigilance (PV): End-use Estimates & Trend Analysis

Chapter 7 Pharmacovigilance (PV): Industrial End-use Estimates & Trend Analysis

Chapter 8 Pharmacovigilance (PV): Regional Estimates & Trend Analysis

Chapter 9 Competitive Landscape

Chapter 10 Pharmacovigilance (PV): Manufacturers Company Profiles

 

Top Key Players of Global Pharmacovigilance (PV) Market :

United BioSource Corporation, Accenture, Wipro Ltd., Clinquest Group B.V., BioClinica, Cognizant, PAREXEL International Corporation, Laboratory Corporation of America Holdings, TAKE Solutions Ltd., IBM Corporation, Foresight Group International AG, ArisGlobal, and iMEDGlobal.

 

Know More Insights @ https://newsonmarketblog.wordpress.com

 

 

Thursday, July 16, 2020

Pharmacovigilance (PV) Market Global Status and Forecast Report by 2025


Latest Research Report on Pharmacovigilance (PV) Market begins with a deep introduction and then delves broad into specific segments such as raw material, application, end user, and region, policy study, value chain structure, and upcoming trends in particular segments or regions. The report on Pharmacovigilance (PV) prepare a case for investments in different regions based on a practical view of their regulatory outline, manufacturing dynamics, and availability of skills and resources in that region.

Pharmacovigilance (PV) Market Report by Material, Application, and Geography – Global Forecast to 2025 is a professional and in-depth research report on the world’s major regional Pharmacovigilance (PV) Market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).


The global Pharmacovigilance (PV) Market size is estimated to reach USD 10.27 billion by 2025, registering at a 13.1% CAGR over the forecast period as the scope and its applications are rising enormously across the globe. Pharmacovigilance (PV) is also termed as drug safety, is a science and activities relating to the prevention, detection, understanding, and assessment of adverse effects or other drug-related issues.

The factors that are playing a major role in the growth of pharmacovigilance market are the rising occurrence of adverse drug reactions (ADR), enhancement in development of ADR database and information system, and the rising demand from the end-users. Pharmacovigilance (PV) industry is segmented based on the clinical trial phase, service provider, type of methods, end-user, and region.

Phase IV, phase III, phase II, phase I, and pre-clinical are the clinical trial phase that could be explored in pharmacovigilance (PV) market in the forecast period. The phase IV sector accounted for the substantial market share of pharmacovigilance and is estimated to lead the overall market in the years to come. Also, phase III sector is estimated to show lucrative growth in the years to come. Contract outsourcing, in-house, and other service providers could be explored in pharmacovigilance industry in the forecast period. Contract outsourcing sector accounted for the substantial market share of pharmacovigilance and is estimated to lead the overall market in the years to come.

Based on the type of method, HER mining, spontaneous reporting, cohort event monitoring, intensified ADR reporting, targeted spontaneous reporting, and others could classify pharmacovigilance market in the forecast period. Spontaneous report sector accounted for the significant market share of pharmacovigilance and is estimated to continue its dominance in the years to come. Also, the cohort event monitoring sector is estimated to grow at the fastest pace in the years to come.

The market may be categorized based on end-users like industrial, hospitals, research organizations, and others that could be explored in the forecast period. The hospitals sector accounted for the substantial market share of pharmacovigilance and is estimated to lead the overall market in the years to come. Also, the research organization sector is estimated to grow at the fastest pace in the years to come.

Globally, North America accounted for the substantial share of pharmacovigilance industry and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be the presence of key manufacturers in the region and the high investment in the development of new drugs. The United States and Canada are the major consumers of pharmacovigilance in the years to come.

Europe and the Asia Pacific are also estimated to have a positive influence on future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at the highest CAGR in the forecast period. The developing countries like India and China are the major consumers of pharmacovigilance in this region.

The key players of pharmacovigilance (PV) industry are United BioSource Corporation, Accenture, Wipro Ltd., Clinquest Group B.V., BioClinica, Cognizant, PAREXEL International Corporation, Laboratory Corporation of America Holdings, TAKE Solutions Ltd., IBM Corporation, Foresight Group International AG, ArisGlobal, and iMEDGlobal. These players are concentrating on inorganic growth to sustain themselves amidst fierce competition.